Esophageal and Gastroesophageal Junction Carcinoma

Esophageal and Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,309 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 460
Recruiting: 254
Ph III recruiting: 40
Growth YoY: +36.1%
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (120)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07533825	Laparoscopic Staging for Stage III Gastric Cancer(CGCA202501)	enrolling by invitation	N/A	968	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Apr 16, 2026	clinicaltrials
NCT06990178	Adaptive Neoadjuvant Therapy for Esophageal Cancer	enrolling by invitation	N/A	43	Cancer Hospital Chinese Academy of Medical Science, Shenzhen CenterOTHER	1	May 25, 2025